Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Loading...
January 17, 2022
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local economy. The recent pandemic has shown the huge value of diagnostics and tuberculosis (TB), for which there are currently few...
Innovation directed at an unmet market need can stimulate economic development if the value creation is kept within the local...
December 10, 2021
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is appointing Jane Theaker, of precision medicine company Kinomica, as the new CEO and bringing Commercial Director, Jonnie Yewdall, into a...
PBD Biotech, developers of a phage-based diagnostic for tuberculosis, is moving to the next stage of its development. It is...
September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored by PBD Biotech through the BBSRC CASE initiative, and was co-authored by fellow Nottingham student Philip J. Hill and PBD...
September 22, 2021
Albert’s research, ‘Use of 2, 3, 5-Triphenyltetrazolium chloride (TTC) to assay the kinetics of phage and host interactions’, is sponsored...
September 7, 2021
Farmed deer are susceptible to Johne’s Disease, a chronic wasting condition that results in reduced meat yields, lower fertility and premature death. The condition is difficult to detect, but now a proof of concept study has shown that a new...
September 7, 2021
Farmed deer are susceptible to Johne’s Disease, a chronic wasting condition that results in reduced meat yields, lower fertility and...
August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a shortlisting in the Agri-Tech Innovator of the Year of the British Farming Awards.
August 13, 2021
A new test that has the potential to eradicated bovine TB (bTB) and Johne's Disease has gained PBD Biotech a...
August 11, 2021
Bovine tuberculosis is a chronic, infectious disease caused by the slow growing bacterium Mycobacterium bovis. It can infect humans, livestock, wildlife, and exotic species.
August 11, 2021
Bovine tuberculosis is a chronic, infectious disease caused by the slow growing bacterium Mycobacterium bovis. It can infect humans, livestock,...
June 30, 2021
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache at an Agri-TechE hosted webinar.
Former dairy farmer Jonnie Yewdall joined vets, farmers and others to discuss a new hope of ending the bTB heartache...
May 26, 2021
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to take its Actiphage® blood test for bovine TB (bTB) and Johne’s Disease through the validation required for international industry acceptance.
Jonnie Yewdall, a former dairy farmer, has been appointed Commercial Director at PBD Biotech. The company recently gained funding to...
May 14, 2021
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK, and we don’t appear to be getting on top of it. We need many more tools in the toolbox in...
“From an industry perspective bovine tuberculosis (bTB) is a huge problem – the disease continues to move across the UK,...
18 May 2021
May 5, 2021
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare for some dairy farmers for years. Dr Cath Rees, Chief Scientific Officer, PBD Biotech, developers of an accurate blood and...
Businesses across the country have seen for themselves the impact of pandemic – but this has been the living nightmare...
March 26, 2021
PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health (OIE). Full validation will enable international adoption of this novel, patented, diagnostic for mycobacterial diseases, which include human tuberculosis and...
PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health...
February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood or milk, has been awarded the Innovation Award 2021 (15th February 2021) by Veterinary Record, the official journal of the...
February 16, 2021
Actiphage®, a rapid, accurate test for tuberculosis that detects the presence of the live mycobacteria in a sample of blood...